Hyaluronic Acid 140 mg

It offers stronger or broader active quality by using 140 mg of branded low-molecular-weight Injuv for a clearly characterized oral hyaluronic acid complex. Compared with the original’s 140 mg comb-derived active, the candidate changes the source, delivery detail, or supporting ingredients; the focused active is well matched to skin and joint use, though the candidate does not add broader structural ingredients.

It offers stronger or broader active quality by delivering 120 mg of sodium hyaluronate with a small hydrolyzed fish-collagen addition. Compared with the original’s 140 mg comb-derived active, the candidate changes the source, delivery detail, or supporting ingredients; the collagen amount is too small to add much and creates a fish-allergen concern.

It offers stronger or broader active quality by combining 5 g of hydrolyzed marine collagen, 90 mg of vitamin C, and 60 mg of sodium hyaluronate. Compared with the original’s 140 mg comb-derived active, the candidate changes the source, delivery detail, or supporting ingredients; hyaluronic acid is lower than in focused high-dose products, while undisclosed collagen species may matter for fish allergy.

It lowers recurring cost while providing 200 mg of clearly identified sodium hyaluronate at very low recurring cost. Compared with the original’s 140 mg comb-derived active, the candidate changes the source, delivery detail, or supporting ingredients; molecular weight is not stated, but the focused amount is higher than most candidates.

It lowers recurring cost while supplying a simple 100 mg hyaluronic acid softgel with favorable serving economics. Compared with the original’s 140 mg comb-derived active, the candidate changes the source, delivery detail, or supporting ingredients; molecular weight and production source are not disclosed, and the amount is below stronger oral ranges.

It lowers recurring cost while pairing 100 mg of sodium hyaluronate with 100 mg of proline and small pine-bark and grape-seed extracts. Compared with the original’s 140 mg comb-derived active, the candidate changes the source, delivery detail, or supporting ingredients; molecular weight and extract standardization are absent, so the supporting ingredients add breadth more than proven dose depth.

It offers a practical quality-to-cost balance by using a 140 mg low-molecular-weight Injuv complex with strong supplied alignment to skin and useful joint support. Compared with the original’s 140 mg comb-derived active, the candidate changes the source, delivery detail, or supporting ingredients; the active is well characterized, but its serving value is weaker than several simpler hyaluronic acid options.

It offers a practical quality-to-cost balance by combining 100 mg of sodium hyaluronate with proline plus pine-bark and grape-seed extracts in a reasonably priced formula. Compared with the original’s 140 mg comb-derived active, the candidate changes the source, delivery detail, or supporting ingredients; molecular weight and extract standardization are missing, while the supporting botanicals are modest.

It offers a practical quality-to-cost balance by combining 50 mg of sodium hyaluronate with glucosamine sulfate, chondroitin sulfate, and methylsulfonylmethane for broader joint support. Compared with the original’s 140 mg comb-derived active, the candidate changes the source, delivery detail, or supporting ingredients; the hyaluronic acid amount is modest and the other joint actives sit below stronger focused amounts.